Skip to main content
TipRanks
Go Ultimate75% OFF

Pure Bioscience (PURE) Ratios

47 Followers

Pure Bioscience Ratios

PURE's free cash flow for Q4 2026 was $-414.00K. For the 2026 fiscal year, PURE's free cash flow was increased by $0.00 and operating cash flow was $-414.00K. See a summary of the company’s cash flow.

Financial ratios
RatiosJul 26Jul 25Jul 24Jul 23Jul 22
Liquidity Ratios
Current Ratio0.271.121.103.026.72
Quick Ratio0.230.971.022.856.41
Cash Ratio0.13356.080.482.065.90
Solvency Ratio-0.33-0.39-0.87-2.48-5.71
Operating Cash Flow Ratio-0.40-2.15-3.45-6.16-4.21
Short-Term Operating Cash Flow Coverage-0.510.000.000.000.00
Net Current Asset Value$ -6.41M$ -5.13M$ -2.88M$ 51.00K$ 3.29M
Leverage Ratios
Debt-to-Assets Ratio5.530.493.610.560.00
Debt-to-Equity Ratio-1.03-0.10-1.033.750.00
Debt-to-Capital Ratio32.52-0.1134.690.790.00
Long-Term Debt-to-Capital Ratio-1.01-0.1134.690.790.00
Financial Leverage Ratio-0.19-0.21-0.296.711.15
Debt Service Coverage Ratio-0.55-7.02-19.66-273.57-545.33
Interest Coverage Ratio-5.12-7.60-20.20-281.64-570.83
Debt to Market Cap0.890.050.330.110.00
Interest Debt Per Share0.060.010.030.010.00
Net Debt to EBITDA-2.90158.95-0.850.021.04
Profitability Margins
Gross Profit Margin57.20%59.17%58.69%51.73%53.97%
EBIT Margin-89.86%-95.37%-162.76%-210.28%-188.07%
EBITDA Margin-89.86%-95.28%-155.22%-204.05%-176.58%
Operating Profit Margin-89.86%-103.18%-159.50%-210.07%-184.84%
Pretax Profit Margin-107.12%-108.95%-170.66%-211.03%-188.40%
Net Profit Margin-107.12%-108.95%-170.66%-211.03%-188.72%
Continuous Operations Profit Margin-107.12%-108.95%-170.66%-211.03%-188.40%
Net Income Per EBT100.00%100.00%100.00%100.00%100.17%
EBT Per EBIT119.20%105.59%106.99%100.46%101.93%
Return on Assets (ROA)-208.13%-226.75%-409.54%-217.04%-77.99%
Return on Equity (ROE)38.80%46.89%116.97%-1456.25%-89.46%
Return on Capital Employed (ROCE)65.54%-1893.33%-3683.53%-304.95%-87.62%
Return on Invested Capital (ROIC)-1026.11%-20.45%-3683.53%-304.95%-87.62%
Return on Tangible Assets-208.13%-226.75%-409.54%-217.04%-77.99%
Earnings Yield-33.31%-23.88%-37.53%-41.83%-19.98%
Efficiency Ratios
Receivables Turnover6.944.656.596.599.22
Payables Turnover1.211.151.352.151.75
Inventory Turnover5.146.3814.4810.304.77
Fixed Asset Turnover289.750.20151.008.492.99
Asset Turnover1.942.082.401.030.41
Working Capital Turnover Ratio-1.5124.333.430.860.67
Cash Conversion Cycle-178.11-182.49-189.87-79.14-92.63
Days of Sales Outstanding52.5978.5755.4155.4239.59
Days of Inventory Outstanding71.0157.2525.2035.4576.59
Days of Payables Outstanding301.71318.31270.49170.01208.82
Operating Cycle123.61135.8280.6190.87116.19
Cash Flow Ratios
Operating Cash Flow Per Share-0.01-0.02-0.02-0.03-0.03
Free Cash Flow Per Share-0.01-0.02-0.02-0.03-0.03
Dividend Paid and CapEx Coverage Ratio0.000.000.00-99.33-29.85
Capital Expenditure Coverage Ratio0.000.000.00-99.33-29.85
Operating Cash Flow Coverage Ratio-0.26-3.85-0.86-3.210.00
Operating Cash Flow to Sales Ratio-0.75-0.92-1.29-1.75-1.30
Free Cash Flow Yield-23.32%-20.06%-28.35%-34.97%-14.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-3.00-4.20-2.66-2.39-5.00
Price-to-Sales (P/S) Ratio3.224.564.555.049.44
Price-to-Book (P/B) Ratio-1.16-1.96-3.1234.814.48
Price-to-Free Cash Flow (P/FCF) Ratio-4.29-4.99-3.53-2.86-7.00
Price-to-Operating Cash Flow Ratio-4.29-4.99-3.53-2.89-7.24
Price-to-Earnings Growth (PEG) Ratio6.430.150.170.25-0.10
Enterprise Value Multiple-6.47154.16-3.78-2.45-4.31
Enterprise Value13.49M-323.43M11.53M9.40M14.11M
EV to EBITDA-6.47154.16-3.78-2.45-4.31
EV to Sales5.82-146.885.875.017.61
EV to Free Cash Flow-7.76160.51-4.55-2.84-5.65
EV to Operating Cash Flow-7.76160.51-4.55-2.87-5.84
Tangible Book Value Per Share-0.05-0.05-0.030.000.04
Shareholders’ Equity Per Share-0.05-0.05-0.030.000.04
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.020.020.020.020.02
Net Income Per Share-0.02-0.02-0.03-0.04-0.04
Tax Burden1.001.001.001.001.00
Interest Burden1.191.141.051.001.00
Research & Development to Revenue0.140.140.150.160.17
SG&A to Revenue1.331.480.000.000.00
Stock-Based Compensation to Revenue0.080.070.110.170.31
Income Quality0.700.840.760.830.69

Currency in USD